Patents Assigned to VIVASOLIS BIOTECHNOLOGY CO., LTD.
  • Publication number: 20200172609
    Abstract: The preset invention relates to preventing, arresting, reversing or treating atherosclerosis, comprising a step of: administering to a subject in need thereof a therapeutically effective amount of a macrophage inflammatory protein-1 beta (MIP-1?) inhibitor.
    Type: Application
    Filed: August 10, 2018
    Publication date: June 4, 2020
    Applicants: NATIONAL YANG-MING UNIVERSITY, TAIPEI VETERANS GENERAL HOSPITAL, VIVASOLIS BIOTECHNOLOGY CO., LTD.
    Inventor: Jaw-Wen CHEN